Clinical Trial Update: Safety and Impact of Baricitinib on Cell Surivival Pathways, HIV-1 Reservoir and Inflamation in People With HIV-1 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating baricitinib for safety and impact on HIV-1 reservoirs and inflammation in people with HIV-1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Baricitinib (baricitinib)

Snippet

Sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | Conditions: HIV | Phase 2 | Status: ACTIVE_NOT_RECRUITING